rs121909730
Variant summary
Our verdict is Pathogenic. Variant got 10 ACMG points: 10P and 0B. PM2PP5_Very_Strong
The NM_005271.5(GLUD1):c.1519C>T(p.His507Tyr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Consequence
NM_005271.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 10 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 29
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hyperinsulinism-hyperammonemia syndrome Pathogenic:3
- -
- -
This variant is also known as p.H454Y. ClinVar contains an entry for this variant (Variation ID: 16121). Algorithms developed to predict the effect of missense changes on protein structure and function are either unavailable or do not agree on the potential impact of this missense change (SIFT: "Not Available"; PolyPhen-2: "Benign"; Align-GVGD: "Not Available"). For these reasons, this variant has been classified as Pathogenic. This missense change has been observed in individual(s) with familial hyperinsulinism-hyperammonemia syndrome (PMID: 9571225, 26839063, 30252420; Invitae). In at least one individual the variant was observed to be de novo. This sequence change replaces histidine, which is basic and polar, with tyrosine, which is neutral and polar, at codon 507 of the GLUD1 protein (p.His507Tyr). This variant is not present in population databases (gnomAD no frequency). -
Familial hyperinsulinemia Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at